The growing interest in nanomedicine over the last 20 years has carved out a research field
called “nanocatalytic therapy,” where catalytic reactions mediated by nanomaterials are …

Nanozymes, nanomaterials with enzyme‐mimicking activity, have attracted tremendous
interest in recent years owing to their ability to replace natural enzymes in various …

Abstract Development of novel therapies for central nervous system (CNS) disorders has
experienced a high failure rate in clinical trials owing to unsatisfactory efficacy and adverse …

Nanotechnology has been a boon for the biomedical field due to the freedom it provides for
tailoring of pharmacokinetic properties of different drug molecules. Nanomedicine is the …

Background: The excess production of reactive oxygen species (ROS) after traumatic spinal
cord injury (TSCI) has been identified as a leading cause of secondary injury, which can …

Advances in nanotechnology have enabled the design of nanotherapeutic platforms that
could address the challenges of targeted delivery of active therapeutic agents to the central …

Ceria (CeO2) nanostructures are well-known in catalysis for energy and environmental
preservation and remediation. Recently, they have also been gaining momentum for …

The prevalence of neurological/neurodegenerative diseases, such as Alzheimer's disease is
known to be increasing due to an aging population and is anticipated to further grow in the …

Inflammatory microenvironments (IMEs) are common pathological characteristics and drive
the development of multiple chronic diseases. Thus, IME-targeted therapies exhibit potential …

Nanoparticles (NPs) that target multiple transport mechanisms facilitate targeted delivery of
active therapeutic agents to the central nervous system (CNS) and improve therapeutic …